Jan Balvan

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Scientific reports

Biomedical optics express

Metallomics : integrated biometal science

Angewandte Chemie (International ed. in English)

Masaryk University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Masaryk University Sep 1o 2013 - Nov 9o 2017

Czechia

PHD :: Department of Physiology

Publications

Xia Peng, Mario Urso, Jan Balvan, Michal Masařík, Martin Pumera
Self-Propelled Magnetic Dendrite-Shaped Microrobots for Photodynamic Prostate Cancer Therapy. Angewandte Chemie (International ed. in English) 61 (48) (2022)
Barbora Peltanova, Hana Holcova Polanska, Martina Raudenska, Jan Balvan, Jiří Navrátil, Tomáš Vičar, Jaromir Gumulec, Barbora Čechová, Martin Kräter, Jochen Guck, David Kalfeřt, Marek Grega, Jan Plzák, Jan Betka, Michal Masařík
mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells. Cancers 14 (9) (2022)
Martina Raudenska, Monika Kratochvilova, Tomáš Vičar, Jaromir Gumulec, Jan Balvan, Hana Polanska, Jan Pribyl, Michal Masařík
Author Correction: Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation. Scientific reports 12 (1) (2022)
Tomáš Vičar, Jiri Chmelik, Roman Jakubicek, Larisa Chmelikova, Jaromir Gumulec, Jan Balvan, Ivo Provaznik, Radim Kolar
Self-supervised pretraining for transferable quantitative phase image cell segmentation. Biomedical optics express 12 (10) (2021)
Martina Raudenska, Jaromir Gumulec, Jan Balvan, Michal Masařík
Caveolin-1 in oncogenic metabolic symbiosis. International journal of cancer 147 (7) (2020)
Martina Raudenska, Jan Balvan, Michaela Fojtu, Jaromir Gumulec, Michal Masařík
Unexpected therapeutic effects of cisplatin. Metallomics : integrated biometal science 11 (7) (2020)
Martina Raudenska, Monika Kratochvilova, Tomáš Vičar, Jaromir Gumulec, Jan Balvan, Hana Polanska, Jan Pribyl, Michal Masařík
Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation. Scientific reports 9 (1) (2019)

Jan Balvan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jan Balvan